Log in to save to my catalogue

Implications of using whole genome sequencing to test unselected populations for high risk breast ca...

Implications of using whole genome sequencing to test unselected populations for high risk breast ca...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4888520

Implications of using whole genome sequencing to test unselected populations for high risk breast cancer genes: a modelling study

About this item

Full title

Implications of using whole genome sequencing to test unselected populations for high risk breast cancer genes: a modelling study

Publisher

Poland: BioMed Central Ltd

Journal title

Hereditary cancer in clinical practice, 2016-06, Vol.14 (1), p.12-12, Article 12

Language

English

Formats

Publication information

Publisher

Poland: BioMed Central Ltd

More information

Scope and Contents

Contents

The decision to test for high risk breast cancer gene mutations is traditionally based on risk scores derived from age, family and personal cancer history. Next generation sequencing technologies such as whole genome sequencing (WGS) make wider population testing more feasible. In the UK's 100,000 Genomes Project, mutations in 16 genes including BR...

Alternative Titles

Full title

Implications of using whole genome sequencing to test unselected populations for high risk breast cancer genes: a modelling study

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4888520

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4888520

Other Identifiers

ISSN

1897-4287,1731-2302

E-ISSN

1897-4287

DOI

10.1186/s13053-016-0052-7

How to access this item